Hans‐Peter Tony
- Immunology top 1%
- Rheumatology top 0.5%
- Oncology top 5%
- Hematology top 1%
- Radiology, Nuclear Medicine and Imaging top 2%
- Co-authors
- Thomas DörnerPetra RollJoel M. KremerAntonio SánchezEdward KeystoneEmma AlecockRonald van VollenhovenAlain Cantagrel
- Topics
- Rheumatoid Arthritis Research and Therapies (50 papers)Monoclonal and Polyclonal Antibodies Research (32 papers)T-cell and B-cell Immunology (26 papers)
- Cited by
- RheumatologyImmunologyHematology
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Hans‐Peter Tony
149 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Immunology 2.1k
- Rheumatology 1.6k
- Oncology 866
- Hematology 803
- Radiology, Nuclear Medicine and Imaging 685
Countries citing papers authored by Hans‐Peter Tony
This map shows the geographic impact of Hans‐Peter Tony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Peter Tony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Peter Tony more than expected).
Fields of papers citing papers by Hans‐Peter Tony
This network shows the impact of papers produced by Hans‐Peter Tony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Peter Tony. The network helps show where Hans‐Peter Tony may publish in the future.
Co-authorship network of co-authors of Hans‐Peter Tony
This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Peter Tony. A scholar is included among the top collaborators of Hans‐Peter Tony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Peter Tony. Hans‐Peter Tony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 34 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 11 | |
| 5 | 9 | |
| 6 | Comparison of Switching from the Originator Rituximab to the Biosimilar Rituximab GP2013 or Re-Treatment with the Originator Rituximab in Patients with Active Rheumatoid Arthritis: Safety and Immunogenicity Results from a Multicenter, Randomized, Double-Blind Study | 2 |
| 7 | 4 | |
| 8 | 1 | |
| 9 | 78 | |
| 10 | 25 | |
| 11 | 2 | |
| 12 | 143 | |
| 13 | 19 | |
| 14 | 26 | |
| 15 | [Current therapeutic strategy for rheumatoid arthritis]. | 3 |
| 16 | 12 | |
| 17 | 1 | |
| 18 | 34 | |
| 19 | 37 | |
| 20 | 75 |
About Hans‐Peter Tony
Hans‐Peter Tony is a scholar working on Rheumatology, Immunology and Genetics, having authored 151 papers that have together received 4.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (50 papers), Monoclonal and Polyclonal Antibodies Research (32 papers) and T-cell and B-cell Immunology (26 papers). The work is most often cited by research in Rheumatology (1.6k citations), Immunology (2.1k citations) and Hematology (803 citations). Hans‐Peter Tony has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Thomas Dörner, Petra Roll, Joel M. Kremer, Antonio Sánchez, Edward Keystone, Emma Alecock, Ronald van Vollenhoven, Alain Cantagrel, Paul Emery and Martin Wilhelm. Their work appears in journals such as The Journal of Experimental Medicine, The EMBO Journal and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.